Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antihistamine (H2)   Ranitidine hydrochloride  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Acloral Mexico
Antak
Azantac
B-Alcerin
Coralen
Epadoren Greece
Histac
Logat
Lumaren Greece
Pep rani
Peptoran
Ptinolin Greece
Ranic
Ranidil Italy
Ranigast Poland
Ranisan
Ranitab Turkey
Ranital
Ranitic Germany
Ranitidin Germany
Rantag Germany
Rinavian Argentina
Solvertyl
Stacer
Taural
Ulcuran Turkey
Ulsal Austria
Zantac Belgium, Denmark, Great Britain, Greece, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Thailand, Turkey, United States of America
Zantic Switzerland
Zydac Saudi Arabia
Zylium Brazil
Stability of mixtures   Injection   Stability of mixtures : Ranitidine hydrochloride     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Not specified 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Aztreonam 8,6 mg/ml
23°C
4 Hour
Light 360
Level of evidence B
Glass Not specified 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Ceftazidime 10 mg/ml
23°C
4 Hour
Light 360
Level of evidence B
Glass NaCl 0,9% or Glucose 5% 1 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Cefmetazole sodium 20 mg/ml
22°C-23°C
2 Hour
Light 903
Level of evidence A
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Aztreonam 8,6 mg/ml
22°C-23°C
4 Hour
Light 360
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Ceftazidime 10 mg/ml
22°C-23°C
4 Hour
Light 360
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Piperacillin sodium 15 mg/ml
22°C-23°C
4 Hour
Light 360
Level of evidence B
Glass Sodium chloride 0,9% 1 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Cefmetazole sodium 10 mg/ml
22°C-23°C
4 Hour
Light 903
Level of evidence A
Glass Sodium chloride 0,9% 0,5 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Piperacillin sodium / tazobactam 80/10 mg/ml
23°C
4 Hour
Light 235
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Moxalactam 10 mg/ml
25°C
2 Hour
Light 934
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Ceftizoxime sodium 10 mg/ml
25°C
4 Hour
Light 934
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Cefoperazone sodium 10 mg/ml
25°C
4 Hour
Light 934
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Cefmenoxime 10 mg/ml
25°C
4 Hour
Light 934
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Cefuzonam 10 mg/ml
25°C
4 Hour
Light 934
Level of evidence B
Glass Sodium chloride 0,9% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Cefazolin sodium 20 mg/ml
25°C
4 Hour
2355
Level of evidence D
Glass Glucose 5% 0,6 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Labetalol hydrochloride 1 mg/ml
20°C-25°C
4 Hour
Light 199
Level of evidence A
Glass Glucose 5% 0,85 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Milrinone lactate 0,2 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,5 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Paclitaxel 0,3 & 1,2 mg/ml
23°C
4 Hour
Light 47
Level of evidence A
Glass Glucose 5% 2,0 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Paclitaxel 1,2 mg/ml
Injection   Ondansetron hydrochloride 0,3 mg/ml
23°C
4 Hour
Light 47
Level of evidence A
Glass Glucose 5% 0,5 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Ondansetron hydrochloride 0,03 & 0,3 mg/ml
25°C
4 Hour
Light 18
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Zidovudine 2 mg/ml
23°C
24 Hour
Light 1900
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Zidovudine 2 mg/ml
4°C
24 Hour
Protect from light 1900
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Aminophylline 0,5 & 2 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Lidocaine hydrochloride 1 & 8 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Dobutamine hydrochloride 0,25 & 1 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Nitroprusside sodium 0,05 & 0,4 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Dopamine hydrochloride 0,4 & 3,2 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Insulin 1 UI/ml
25°C
1 Hour
Light 208
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 0,05 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Methylprednisolone sodium succinate 0,04 mg/ml
?
24 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 0,05 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Methylprednisolone sodium succinate 2 mg/ml
?
24 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Methylprednisolone sodium succinate 0,04 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 0,3 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Flumazenil 0,02 mg/ml
23°C
24 Hour
Light 187
Level of evidence A
Polyvinyl chloride Glucose 5% 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Norepinephrine bitartrate 0,004 mg/ml
?
4 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Norepinephrine bitartrate 0,008 mg/ml
?
12 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 0,05 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Norepinephrine bitartrate 0,004 & 0,008 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 0,05 & 2 mg/ml
Injection   Ranitidine hydrochloride   
Injection   Methylprednisolone sodium succinate 0,04 & 2 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
  Mentions Légales